NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

Well, it could be.

As I mentioned before, if you read Dr. Liau's publications, you can see that she always cites the latest publications in GBM field. But if you read the JAMA paper, you can see from the data lock of Oct. 2020 to the publication of the JAMA paper no new publications were cited from this time interval except one about the terminology and the FDA publication on ECA with Donna Riveria as one of the coauthors. My conjecture is that the paper was ready for publication after the data lock. But LP had to wait for something else to be ready. That's why I suggest the longs pay special attention to any massive construction of biologic facilities from BPs after the data lock.

https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847